Literature DB >> 222440

Effects of protease inhibitors on chemical induction of type C virus.

C W Long, J A Bruszewski, W L Christensen, W A Suk.   

Abstract

A role for proteolysis during chemical induction of endogenous xenotropic Type C virus from Kirsten sarcoma virus-transformed mouse cells was examined. Two distinct classes of protease inhibitors, the trypsin inhibitor, alpha-N-tosyl-L-lysine chloromethyl ketone, and two naturally occurring oligopeptide inhibitors, antipain and leupeptin, were found to inhibit induction of virus by cycloheximide and histidinol. Virus activation by 5-iododeoxyuridine was inhibited to a lesser degree. During the time cells were exposed to these compounds, there was little inhibition of [3H]uridine incorporation into total cellular RNA or polyadenylic acid cytoplasmic messenger RNA, suggesting that inhibition of proteolysis, and not RNA transcription, was responsible for blocking virus induction.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 222440

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Induction of endogenous xenotropic retrovirus expression by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate.

Authors:  W A Suk; C W Long
Journal:  In Vitro Cell Dev Biol       Date:  1986-05

2.  Mechanisms of expression of herpes simplex virus-common surface antigens in clonal cells of a herpes simplex virus type 2-transformed line.

Authors:  K Okazaki; Y Ohnishi; N Yoshida; S Kimura
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

3.  Amino acid analogs inhibit murine xenotropic retrovirus expression and cell cycle progression.

Authors:  W R Suk; R M Snead; C W Long
Journal:  In Vitro       Date:  1984-02

4.  Juvenile hormones inhibit murine cell cycle progression and expression of type C viruses.

Authors:  W A Suk; L M Ceccorulli; C W Long
Journal:  In Vitro       Date:  1981-05

5.  Leupeptin inhibits retrovirus infection in mouse fibroblasts.

Authors:  K B Andersen
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.